{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:24:29Z","timestamp":1790709869803,"version":"4.1.0"},"reference-count":92,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["R01NS082347"],"award-info":[{"award-number":["R01NS082347"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National MS Society","doi-asserted-by":"publisher","award":["RG-1606-08768"],"award-info":[{"award-number":["RG-1606-08768"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National MS Society","doi-asserted-by":"publisher","award":["TR-3760-A-3"],"award-info":[{"award-number":["TR-3760-A-3"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National MS Society","doi-asserted-by":"publisher","award":["RG-4212-A-4"],"award-info":[{"award-number":["RG-4212-A-4"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National MS Society","doi-asserted-by":"publisher","award":["RG-1507-05243"],"award-info":[{"award-number":["RG-1507-05243"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014842","name":"Race to Erase MS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014842","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Intramural Research Program"},{"name":"Walters Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/brain\/awy245","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T19:43:15Z","timestamp":1535658195000},"page":"3115-3129","source":"Crossref","is-referenced-by-count":87,"title":["Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study"],"prefix":"10.1093","volume":"141","author":[{"given":"Natalia Gonzalez","family":"Caldito","sequence":"first","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Saidha","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias S","family":"Sotirchos","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake E","family":"Dewey","sequence":"additional","affiliation":[{"name":"F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, MD, USA"},{"name":"Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah J","family":"Cowley","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Glaister","sequence":"additional","affiliation":[{"name":"Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn C","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Al-Louzi","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, MA, USA"},{"name":"Department of Neurology, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Rothman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Ogbuokiri","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Fioravante","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohemaa","family":"Kwakyi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Risher","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorlan","family":"Kimbrough","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa C","family":"Frohman","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Texas Austin Dell Medical School, Austin TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Frohman","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Texas Austin Dell Medical School, Austin TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Balcer","sequence":"additional","affiliation":[{"name":"Department of Neurology, New York University Langone Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciprian","family":"Crainiceanu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Johns Hopkins University, Baltimore MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C M","family":"Van Zijl","sequence":"additional","affiliation":[{"name":"Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M","family":"Mowry","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S","family":"Reich","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Department of Biostatistics, Johns Hopkins University, Baltimore MD, USA"},{"name":"Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, USA"},{"name":"Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Division of Neurology, St. Michael\u2019s Hospital, University of Toronto, 30 Bond Street, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzung L","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, USA"},{"name":"Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, USA"},{"name":"Center for Neuroscience and Regenerative Medicine, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Prince","sequence":"additional","affiliation":[{"name":"Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Calabresi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"key\n\t\t\t\t2018102604002814800_awy245-B1","doi-asserted-by":"crossref","unstructured":"Agosta F , RovarisM, PaganiE, SormaniMP, ComiG, FilippiM. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain2006; 129 (Pt 10): 2620\u20137.","DOI":"10.1093\/brain\/awl208"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B2","doi-asserted-by":"crossref","unstructured":"Al-louzi O , BhargavaP, NewsomeSD, BalcerLJ, FrohmanEM, CrainiceanuCet al. Outer retinal changes following acute optic neuritis. Mult Scle2016; 22 : 362\u201372.","DOI":"10.1177\/1352458515590646"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B3","doi-asserted-by":"crossref","unstructured":"Al-louzi O , ButtonJ, NewsomeSD, CalabresiPA, SaidhaS. Retrograde trans-synaptic visual pathway degeneration in multiple sclerosis: a case series. Mult Scler2017; 23: 1035\u201339.","DOI":"10.1177\/1352458516679035"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B4","doi-asserted-by":"crossref","unstructured":"Al-Kawaz M , MonohanE, MorrisE, PerumalJS, NealonN, VartanianTet al. Differential impact of multiple sclerosis on cortical and deep gray matter structures in African Americans and Caucasian Americans. J Neuroimaging2017; 27: 333\u20138.","DOI":"10.1111\/jon.12393"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B5","doi-asserted-by":"crossref","unstructured":"Ascherio A , MungerKL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol2007; 61: 504\u201313.","DOI":"10.1002\/ana.21141"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B6","doi-asserted-by":"crossref","unstructured":"Barboni P , CarelliV, SaviniG, CarbonelliM, La MorgiaC, SadunAA. Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration, Brain2013; 136 (Pt7): e239.","DOI":"10.1093\/brain\/awt014"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B7","doi-asserted-by":"crossref","unstructured":"Bazin PL , PhamDL. Preserving tissue classification of magnetic resonance brain images. IEEE Trans Med Imaging2007; 26: 487\u201396.","DOI":"10.1109\/TMI.2007.893283"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B8","doi-asserted-by":"crossref","unstructured":"Bender R , LangeS. Adjusting for multiple testing when and how?J Clin Epidemiol2001; 54: 343\u20139.","DOI":"10.1016\/S0895-4356(00)00314-0"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B9","doi-asserted-by":"crossref","unstructured":"Bermel RA , BakshiR. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol2006; 5: 158\u201370.","DOI":"10.1016\/S1474-4422(06)70349-0"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B10","doi-asserted-by":"crossref","unstructured":"Bhargava P , LangA, Al-LouziO, CarassA, PrinceJ, CalabresiPA, SaidhaS. Applying an open-source segmentation algorithm to different oct devices in multiple sclerosis patients and healthy controls: implications for clinical trials. Mult Scler Int2015; 136295: 5.","DOI":"10.1155\/2015\/136295"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B92","doi-asserted-by":"crossref","unstructured":"Buss A , BrookGA, KakulasB, MartinD, FranzenR, SchoenenJ, et alGradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain2004; 127: 34\u201344.","DOI":"10.1093\/brain\/awh001"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B11","doi-asserted-by":"crossref","unstructured":"Button J , Al-LouziO, LangA, BhargavaP, NewsomeSD, FrohmanTet al. Disease-modifying therapies modulate retinal atrophy in multiple sclerosis A retrospective study. Neurology2017; 88: 525\u201332.","DOI":"10.1212\/WNL.0000000000003582"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B12","doi-asserted-by":"crossref","unstructured":"Calabrese M , PolettoV, FavarettoA, AlessioS, BernardiV, Romualdi et al. Cortical lesion load associates with progression of disability in multiple sclerosis. Brain2012; 135: 2952\u201361.","DOI":"10.1093\/brain\/aws246"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B13","doi-asserted-by":"crossref","unstructured":"Campbell GR , WorrallJT1, MahadDJ. The central role of mitochondria in axonal degeneration in multiple sclerosis. Mult Scler2014; 20: 1806\u201313.","DOI":"10.1177\/1352458514544537"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B14","doi-asserted-by":"crossref","unstructured":"Cettomai D , PulickenM, Gordon-LipkinE, SalterA, FrohmanTC, CongerAet al. reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol2008; 65: 1218\u201322.","DOI":"10.1001\/archneur.65.9.1218"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B15","unstructured":"Cree BA , KhanO, BourdetteD, GoodinDS, CohenJA, MarrieRAet al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology2004; 63: 2039\u201345."},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B16","doi-asserted-by":"crossref","unstructured":"Cree BA , Al-SabbaghA, BennettR, GoodinD. Response to interferon beta-1a treatment in African American multiple sclerosis patients. Arch Neurol2005; 62: 1681\u20133.","DOI":"10.1001\/archneur.62.11.1681"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B17","doi-asserted-by":"crossref","unstructured":"Cree BA , ReichDE, KhanO, De JagerPL, NakashimaI, TakahashiTet al. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch Neurol2009; 66: 226\u201333.","DOI":"10.1001\/archneurol.2008.541"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B18","doi-asserted-by":"crossref","unstructured":"Criste G , TrappB, DuttaR. Axonal loss in multiple sclerosis: causes and mechanisms. In: GoodinDS editor. Multiple sclerosis and related disorders. Elsevier2014; 122 (Suppl C): 405\u201325.","DOI":"10.1016\/B978-0-444-52001-2.00005-4"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B19","doi-asserted-by":"crossref","unstructured":"Filippi M . MRI measures of neurodegeneration in multiple sclerosis?: implications for disability, disease monitoring, and treatment. J Neurol2015; 262: 1\u20136.","DOI":"10.1007\/s00415-014-7340-9"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B20","doi-asserted-by":"crossref","unstructured":"Fiscella K , SandersMR. Racial and ethnic disparities in the quality of health care. Annu Rev Public Health2016; 37: 375\u201394.","DOI":"10.1146\/annurev-publhealth-032315-021439"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B21","doi-asserted-by":"crossref","unstructured":"Fisniku LK , ChardDT, JacksonJS, AndersonVM, AltmannDR, MiszkielKAet al. Gray matter atrophy is related to long- term disability in multiple sclerosis. Ann Neurol2008; 64: 247\u201354.","DOI":"10.1002\/ana.21423"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B22","doi-asserted-by":"crossref","unstructured":"Gelfand JM , CreeBA, McElroyJ, OksenbergJ, GreenR, MowryEMet al. Vitamin D in African Americans with multiple sclerosis. Neurology2011; 76: 1824\u201330.","DOI":"10.1212\/WNL.0b013e31821cccf5"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B23","doi-asserted-by":"crossref","unstructured":"Geurts JJG, CalabreseM, FisherE, RudickRA. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol2012; 11: 1082\u201392.","DOI":"10.1016\/S1474-4422(12)70230-2"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B24","doi-asserted-by":"crossref","unstructured":"Glaister J , CarassA, StoughJV, CalabresiPA, PrinceJL. Thalamus parcellation using multi-modal feature classification and thalamic nuclei priors. Proc SPIE Int Soc Opt Eng2016; 9784.","DOI":"10.1117\/12.2216987"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B25","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-L\u00f3pez JJ , RebolledaG, LealM, OblancaN, Mu\u00f1oz-NegreteFJ, Costa-FrossardL et al. Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by cirrus and spectralis optical coherence tomography in relapsing-remitting multiple sclerosis. Biomed Res Int2014; 2014: 128517.","DOI":"10.1155\/2014\/128517"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B26","doi-asserted-by":"crossref","unstructured":"Greenberg JD , SpruillTM, ShanY, ReedG, KremerJM, PotterJet al. Racial and ethnic disparities in disease activity in rheumatoid arthritis patients. Am J Med2013; 126: 1089\u201398.","DOI":"10.1016\/j.amjmed.2013.09.002"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B27","doi-asserted-by":"crossref","unstructured":"Han X , PhamDL, TosunD, RettmannME, XuC, PrinceJL. CRUISE?: Cortical reconstruction using implicit surface evolution. Neuroimage2004; 23: 997\u20131012.","DOI":"10.1016\/j.neuroimage.2004.06.043"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B28","doi-asserted-by":"crossref","unstructured":"Harrison DM , ShieeN, BazinPL, NewsomeSD, RatchfordJN, PhamDet al. Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis. J Neurol2013; 260: 397\u2013406","DOI":"10.1007\/s00415-012-6638-8"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B29","doi-asserted-by":"crossref","unstructured":"Herz J , ZippF, SiffrinV. Neurodegeneration in autoimmune CNS inflammation. Exp Neurol2010; 225: 9\u201317.","DOI":"10.1016\/j.expneurol.2009.11.019"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B30","doi-asserted-by":"crossref","unstructured":"Horakova D , KalincikT, DusankovaJB, DolezalO. Clinical correlates of grey matter pathology in multiple sclerosis. BMC Neurol2012; 12: 10.","DOI":"10.1186\/1471-2377-12-10"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B31","doi-asserted-by":"crossref","unstructured":"Howard J , BattagliniM, BabbJS, ArienzoD, HolstB, OmariMet al. MRI Correlates of disability in African-Americans with multiple sclerosis. PLoS One2012; 7: e43061.","DOI":"10.1371\/journal.pone.0043061"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B32","unstructured":"Huang D , SwansonEA, LinCP, SchumanJS, StinsonWG, ChangWet al. Optical coherence tomography. Science1991; 254: 1178\u201381."},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B33","doi-asserted-by":"crossref","unstructured":"Huang R , HughesM, MobleyS, LanhamI, PodusloSE. APOE genotypes in African American female multiple sclerosis patients. Neurosci Lett2007; 414: 51\u20136.","DOI":"10.1016\/j.neulet.2006.12.049"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B34","doi-asserted-by":"crossref","unstructured":"Huo Y , PlassardAJ, CarassA, ResnickSM, PhamDL, PrinceJLet al. NeuroImage consistent cortical reconstruction and multi-atlas brain segmentation. Neuroimage2016; 138: 197\u2013210.","DOI":"10.1016\/j.neuroimage.2016.05.030"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B35","doi-asserted-by":"crossref","unstructured":"Iglesias JE , SabuncuMR. Multi-atlas segmentation of biomedical images?: a survey. Med Image Anal2015; 24: 205\u201319.","DOI":"10.1016\/j.media.2015.06.012"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B36","doi-asserted-by":"crossref","unstructured":"Ikuta F Zimmerman Hm. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurol1976; 26: 26\u201328.","DOI":"10.1212\/WNL.26.6_Part_2.26"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B37","doi-asserted-by":"crossref","unstructured":"Inglese M , OesingmannN, CasacciaP, FleysherL. Progressive multiple sclerosis and gray matter pathology: an MRI perspective. Mt Sinai J Med2011; 78: 258\u201367.","DOI":"10.1002\/msj.20247"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B38","doi-asserted-by":"crossref","unstructured":"Inglese M , GrossmanRI, FilippiM. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution. J Neuroimaging2005; 15 (4Suppl): 22S\u201329S.","DOI":"10.1177\/1051228405282243"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B39","volume-title":"Institute of medicine; board on neuroscience and behavioral health; committee on multiple sclerosis: current status and strategies for the future","author":"Joy","year":"2001"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B40","doi-asserted-by":"crossref","unstructured":"Kaufman MD , JohnsonSK, MoyerD, BivensJ, NortonHJ. Multiple sclerosis severity and progression rate in African Americans compared with whites. Am J Phys Med Rehabil2003; 82: 582\u201390.","DOI":"10.1097\/01.PHM.0000078199.99484.E2"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B41","doi-asserted-by":"crossref","unstructured":"Kaushik M , WangCY, BarnettMH, GarrickR, ParrattJ, GrahamSLet al. Inner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritis. PLoS One2013; 8: e78341.","DOI":"10.1371\/journal.pone.0078341"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B42","doi-asserted-by":"crossref","unstructured":"Khan O , WilliamsMJ, AmezcuaL, JavedA, LarsenKE, SmrtkaJM. Multiple sclerosis in US minority populations: clinical practice insights. Neurol Clin Pract2015; 5: 132\u201342.","DOI":"10.1212\/CPJ.0000000000000112"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B43","doi-asserted-by":"crossref","unstructured":"Kimbrough DJ , SotirchosES, WilsonJA, Al-LouziO, CongerA, CongerDet al. Retinal damage and vision loss in African-American multiple sclerosis patients. Ann Neurol2015; 77: 228\u201336.","DOI":"10.1002\/ana.24308"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B44","unstructured":"Kister I , ChamotE, BaconJH, NiewczykPM, De GuzmanRA, ApatoffBet al. Rapid disease course in African Americans with multiple sclerosis. Neurology2010; 75: 217\u201324."},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B45","volume-title":"Modern epidemiology","author":"Rothman","year":"2008"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B46","doi-asserted-by":"crossref","unstructured":"Knier B , SchmidtP, AlyL, BuckD, BertheleA, M\u00fchlauMet al. Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. Brain2016; 139: 2855\u201363.","DOI":"10.1093\/brain\/aww219"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B47","doi-asserted-by":"crossref","unstructured":"Krishnan E , HubertHB. Ethnicity and mortality from systemic lupus erythematous in the US. Ann Rheum Dis2006; 65: 1500\u20135.","DOI":"10.1136\/ard.2005.040907"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B48","doi-asserted-by":"crossref","unstructured":"Lafata JE , CerghetM, DobieE, SchultzL, TunceliK, ReutherJet al. Measuring adherence and persistence to disease-modifying agents among patients with relapsing remitting multiple sclerosis. J Am Pharm Assoc2008; 48: 752\u20137.","DOI":"10.1331\/JAPhA.2008.07116"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B49","doi-asserted-by":"crossref","unstructured":"Lang A , CarassA, HauserM, SotirchosES, CalabresiPA, YinHSet al. Retinal layer segmentation of macular OCT images using boundary classification. Biomed Opt Express2013; 4: 1133\u201352.","DOI":"10.1364\/BOE.4.001133"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B50","doi-asserted-by":"crossref","unstructured":"Langer-Gould A , BraraSM, BeaberBE, ZhangJL. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology2013; 80: 1734\u201339.","DOI":"10.1212\/WNL.0b013e3182918cc2"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B51","doi-asserted-by":"crossref","unstructured":"Lassmann H . Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol2010; 225: 2\u20138.","DOI":"10.1016\/j.expneurol.2009.10.009"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B52","doi-asserted-by":"crossref","unstructured":"Lublin FD , ReingoldSC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology1996; 46: 907\u201311.","DOI":"10.1212\/WNL.46.4.907"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B53","doi-asserted-by":"crossref","unstructured":"Maldonado RS , MettuP, El-DairiM, BhattiMT. The application of optical coherence tomography in neurologic diseases. Neurol. Clin. Pract2015. 5: 1\u201310.","DOI":"10.1212\/CPJ.0000000000000187"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B54","doi-asserted-by":"crossref","unstructured":"Marrie RA , CutterG, TyryT, VollmerT, CampagnoloD. Does multiple sclerosis\u2013associated disability differ between races. Neurology2006; 66: 1235\u201340.","DOI":"10.1212\/01.wnl.0000208505.81912.82"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B55","doi-asserted-by":"crossref","unstructured":"McLeod DS , CooperDS, LadensonPW, WhitemanDC, JordanSJ. Race\/Ethnicity and the prevalence of thyrotoxicosis in young Americans. Thyroid2015; 25: 621\u20138.","DOI":"10.1089\/thy.2014.0504"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B56","doi-asserted-by":"crossref","unstructured":"Mersha TB , AbebeT. Self-reported race\/ethnicity in the age of genomic research: its potential impact on understanding health disparities. Hum Genomics2015; 9: 1.","DOI":"10.1186\/s40246-014-0023-x"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B57","doi-asserted-by":"crossref","unstructured":"Miller DH , GrossmanRI, ReingoldSC, McFarlandHF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain1998; 121 (Pt1): 3\u201324.","DOI":"10.1093\/brain\/121.1.3"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B58","doi-asserted-by":"crossref","unstructured":"Miller DH . Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx2004; 1: 284\u201394.","DOI":"10.1007\/BF03206612"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B59","doi-asserted-by":"crossref","unstructured":"Minagar A , BarnettMH, BenedictRH, PelletierD, PirkoI, SahraianMAet al. The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology2013; 80: 210\u20139.","DOI":"10.1212\/WNL.0b013e31827b910b"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B60","doi-asserted-by":"crossref","unstructured":"Moss HE , GaoW, BalcerLJ, JoslinCE. Association of race with visual outcomes following acute optic neuritis?: an analysis of the Optic Neuritis Treatment Trial. JAMA Ophthalmol2014; 132: 421\u20137.","DOI":"10.1001\/jamaophthalmol.2013.7995"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B61","doi-asserted-by":"crossref","unstructured":"Naismith RT , TrinkausK, CrossAH. Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Mult Scler2006; 12: 775\u201381.","DOI":"10.1177\/1352458506070923"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B62","unstructured":"Napoli SQ , BakshiR. Magnetic resonance imaging in multiple sclerosis. Rev Neurol Dis2005; 2: 109\u201316."},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B63","unstructured":"N\u00e9d\u00e9lec Y , SanzJ, BaharianG, SzpiechZA, PacisA, DumaineAet al. Genetic ancestry and natural selection drive population differences in immune responses to pathogens. Cell2016; 167: 657\u201369."},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B64","unstructured":"Oksenberg JR , BarcellosLF, CreeBA, BaranziniSE, BugawanTL, KhanOet al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet2004; 74: 160\u20137."},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B65","unstructured":"Parisi L , RoccaMA, MattioliF, RiccitelliGC, CapraR, StampatoriCet al. Gray matter atrophy is related to long-term disability in multiple sclerosis. J Neurol2014; 261: 1715\u201325."},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B66","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Cerd\u00e1 F , S\u00e1nchez-G\u00f3mezMV, MatuteC. The link of inflammation and neurodegeneration in progressive multiple sclerosis. Mult Scler Demyelinating Disord2016; 1: 1\u20138.","DOI":"10.1186\/s40893-016-0012-0"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B67","doi-asserted-by":"crossref","unstructured":"Phillips PH , NewmanNJ, LynnMJ. Optic neuritis in African Americans. Arch Neurol1998; 55: 186\u201392.","DOI":"10.1001\/archneur.55.2.186"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B68","doi-asserted-by":"crossref","unstructured":"Polman CH , ReingoldSC, BanwellB, ClanetM, CohenJA, FilippiMet al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol2011; 69: 292\u2013302.","DOI":"10.1002\/ana.22366"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B69","doi-asserted-by":"crossref","unstructured":"Ratchford JN , SaidhaS, SotirchosES, OhJA, SeigoMA, EcksteinCet al. Active MS is associated with accelerated retinal ganglion cell\/inner plexiform layer thinning. Neurology2013; 80: 47\u201354.","DOI":"10.1212\/WNL.0b013e31827b1a1c"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B70","doi-asserted-by":"crossref","unstructured":"Rebolleda G , Diez-AlvarezL, CasadoA, S\u00e1nchez-S\u00e1nchezC, de DompabloE, Gonz\u00e1lez-L\u00f3pezJJet al. OCT?: New perspectives in neuro-ophthalmology. Saudi J Ophthalmol2015; 29: 9\u201325.","DOI":"10.1016\/j.sjopt.2014.09.016"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B71","doi-asserted-by":"crossref","unstructured":"Reich DS , SmithSA, Gordon-LipkinEM, OzturkA, CaffoBS, BalcerLJ et al. Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch Neurol2009; 66: 998\u20131006.","DOI":"10.1001\/archneurol.2009.107"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B72","doi-asserted-by":"crossref","unstructured":"Rinker JR , TrinkausK, NaismithRT, CrossAH. Higher IgG index found in African Americans versus caucasians with multiple sclerosis. Neurology2007; 69: 68\u201372.","DOI":"10.1212\/01.wnl.0000265057.79843.d9"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B73","doi-asserted-by":"crossref","unstructured":"Romeo M , Martinelli-BoneschiF, RodegherM, EspositoF, MartinelliV, ComiG. Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing\u2013remitting multiple sclerosis patients. Eur J Neurol2013; 20: 1060\u20137.","DOI":"10.1111\/ene.12119"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B74","doi-asserted-by":"crossref","unstructured":"Roy S , HeQ, SweeneyE, CarassA, ReichDS, PrinceJLet al. subject specific sparse dictionary learning for atlas based brain mri segmentation. IEEE J Biomed Health Inform2015; 19: 1598\u2013609.","DOI":"10.1109\/JBHI.2015.2439242"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B75","doi-asserted-by":"crossref","unstructured":"Saidha S , Al-LouziO, RatchfordJN, BhargavaP, OhJ, NewsomeSDet al. Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol2015; 78: 801\u201313.","DOI":"10.1002\/ana.24487"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B76","doi-asserted-by":"crossref","unstructured":"Saidha S , SycSB, IbrahimMA, EcksteinC, WarnerCV, FarrellSKet al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain2011a; 134 (Pt 2): 518\u201333.","DOI":"10.1093\/brain\/awr096"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B77","doi-asserted-by":"crossref","unstructured":"Saidha S , SycSB, DurbinMK, EcksteinC, OakleyJD, MeyerSAet al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness, Mult Scler2011b; 17: 1449\u201363.","DOI":"10.1177\/1352458511418630"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B78","doi-asserted-by":"crossref","unstructured":"Saidha S , SotirchosS, IbrahimMA, CrainiceanuCM, GelfandJM, SepahYJet al. Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol2012; 11: 963\u201372.","DOI":"10.1016\/S1474-4422(12)70213-2"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B79","doi-asserted-by":"crossref","unstructured":"Saidha S , CalabresiPA. \u201cOptical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis?: yes. Mult Scler2014; 20: 1296\u20138.","DOI":"10.1177\/1352458514541509"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B80","doi-asserted-by":"crossref","unstructured":"Seraji-Bozorgzad N , ReedS, BaoF, SantiagoC, TselisA, BernitsasEet al. Characterizing retinal structure injury in African-Americans with multiple sclerosis. Mult Scler Relat Disord2016; 7: 16\u201320.","DOI":"10.1016\/j.msard.2016.02.009"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B81","doi-asserted-by":"crossref","unstructured":"Seraji-Bozorgzad N , KhanO, CreeBAC, BaoF, CaonC, ZakIet al. Cerebral gray matter atrophy is associated with the CSF IgG index in African American with multiple sclerosis. J Neuroimaging2017; 27: 476\u201380.","DOI":"10.1111\/jon.12435"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B82","doi-asserted-by":"crossref","unstructured":"Sicotte NL . Magnetic resonance imaging in multiple sclerosis: the role of conventional imaging. Neurol. Clin Neurol Clin2011; 29: 343\u201356.","DOI":"10.1016\/j.ncl.2011.01.005"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B83","doi-asserted-by":"crossref","unstructured":"Simon JH . Brain atrophy in multiple sclerosis?: what we know and would like to know. Mult Scler2006; 12: 679\u201387.","DOI":"10.1177\/1352458506070823"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B84","doi-asserted-by":"crossref","unstructured":"Simon JH . MRI outcomes in the diagnosis and disease course of multiple sclerosis In: GoodinDS editor. Multiple sclerosis and related disorders. Vol. 122 (supplC). Elsevier; 2014. p. 405\u201325.","DOI":"10.1016\/B978-0-444-52001-2.00017-0"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B85","doi-asserted-by":"crossref","unstructured":"Tang H , QuertermousT, RodriguezB, KardiaSL, ZhuX, BrownAet al. Genetic structure, self-identified race\/ethnicity, and confounding in case-control association studies. Am J Hum Genet2005; 76: 268\u201375.","DOI":"10.1086\/427888"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B86","doi-asserted-by":"crossref","unstructured":"Tewarie P , BalkL, CostelloF, GreenA, MartinR, SchipplingSet al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One2012; 7: e34823.","DOI":"10.1371\/journal.pone.0034823"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B87","unstructured":"Toussaint D , PerierO, VerstappenA, BervoetsS. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol1983; 3: 211\u201320."},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B88","doi-asserted-by":"crossref","unstructured":"Wallin TM , CulpepperWJ, CoffmanP, PulaskiS, MaloniH, MahanCMet al. The gulf war era multiple sclerosis cohort?: age and incidence rates by race, sex and service. Brain2012; 135 (Pt 6): 1778\u201385.","DOI":"10.1093\/brain\/aws099"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B91","doi-asserted-by":"crossref","unstructured":"Wattjes MP , SteenwijkMD, StangelM MRI in the diagnosis and monitoring of multiple sclerosis: an update. Clin Neuroradiol (suppl)2015; 25: 157\u201365.","DOI":"10.1007\/s00062-015-0430-y"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B89","doi-asserted-by":"crossref","unstructured":"Weinstock-Guttman B , RamanathanM, HashmiK, AbdelrahmanN, HojnackiD, DwyerMGet al. Increased tissue damage and lesion volumes in African Americans with multiple sclerosis. Neurology2010; 74: 538\u201344.","DOI":"10.1212\/WNL.0b013e3181cff6fb"},{"key":"key\n\t\t\t\t2018102604002814800_awy245-B90","doi-asserted-by":"crossref","unstructured":"Wolff B , BasdekidouC, VasseurV, Mauget-Fa\u00ffsseM, SahelJA, VignalC. Retinal inner nuclear layer microcystic changes in optic nerve atrophy: a novel spectral-domain OCT finding. Retina2013; 33: 2133\u20138.","DOI":"10.1097\/IAE.0b013e31828e68d0"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/141\/11\/3115\/26172720\/awy245.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T23:44:03Z","timestamp":1661903043000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/141\/11\/3115\/5127751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":92,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,10,11]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awy245","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,10,11]]}}}